Walgreens Tells its Customers to Consider Medical Cannabis

Chris Male of Anslinger Capital shared something today with our almost 4000 member LinkedIn group, Cannabis Investors & Entrepreneurs, that was just too good to be true.  I dismissed it incorrectly...
- April 27th, 2016 at 11:13 pm

OrganiGram Produces Positive Net Income

OrganiGram Reports Results for Fiscal Q2 2016 MONCTON, NEW BRUNSWICK–(Marketwired – April 25, 2016) – OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (the “Company”) today reported its financial results for the...
- April 25th, 2016 at 8:55 am

Aphria Q3 Sales Surge 38% from Q2 to $2.7mm

Aphria Reports Results for Fiscal Q3 2016 Profitable quarter backed by approximately $2.7 million in revenue Year-to-date cash break-even level achieved in quarter LEAMINGTON, ONTARIO–(Marketwired – April 21, 2016)...
- April 21st, 2016 at 8:17 am

GW Pharma's Epidiolex Gains 3rd FDA Orphan Drug Designation

GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex LONDON, April 21, 2016 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP)...
- April 21st, 2016 at 7:38 am

Denver Moves to Limit Cannabis Licenses

The Denver City Council met again last night to discuss the future of marijuana in Denver. Councilwoman Robin Kniech’s proposal, including a few amendments, passed its first reading last...
- April 19th, 2016 at 9:52 pm